Premier Alternatives

BDGENE

Shanghai, China · Founded 2018 · Privately Held (backing)

Developer of gene therapy drugs designed to cure eye diseases. BDGENE is based in Shanghai, China and was founded in 2018. It has raised $40 million.

Last price · $/share
—
Implied valuation
—
Total raised
$40.0M
Last round
—
How much has BDGENE raised?
$40.0Macross 0 recorded rounds
Free account
More of BDGENE with a free account
  • ·The complete investor list: 12 names
  • ·Watch BDGENE: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

BDGENE investors

12 investors are on record for BDGENE, including Innoangel Fund, Lapam Capital, Shenzhen Yifeng Investment Management Enterprise and Tsinghua Holdings Capital.

For fundraisers
Raising for a company like BDGENE?

12 investors have backed BDGENE.

See all 12 investors →

Frequently asked about BDGENE

How much has BDGENE raised?
BDGENE has raised $40.0M in total across 0 recorded funding rounds.